The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTclarke Regulatory News (CTO)

Share Price Information for Tclarke (CTO)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 162.00
Bid: 161.00
Ask: 162.00
Change: 0.50 (0.31%)
Spread: 1.00 (0.621%)
Open: 160.50
High: 162.00
Low: 160.50
Prev. Close: 161.00
CTO Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement & Directorate Change

19 Nov 2015 07:00

RNS Number : 2099G
Clarke(T.) PLC
19 November 2015
 



 

TCLARKE PLC

 

INTERIM MANAGEMENT STATEMENT

AND APPOINTMENT OF NON-EXECUTIVE DIRECTOR

 

 

TClarke plc ("TClarke" or the "Group"), the building services group, today issues an Interim Management Statement covering the period from 1 July 2015 to date.

 

Reflecting the steady improvement in our core markets, the underlying performance of the Group for the year continues to be in line with the Board's expectations.

 

As expected, net debt has reduced during the second half of the year and as at the end of October stood at £6m (30 June 2015: £8.7m) in line with internal forecasts.

 

The Group's order book as at 30 September was 15% higher year-on-year and maintained at the level of £320m reported with the interim results. Of the current forward order book, £190m represents work secured for 2016 and £50m for 2017 and beyond. More pleasingly, we can see a significant improvement in the quality of our order book as we work through the majority of contracts awarded during the down-cycle. We are increasingly confident that this will be reflected in a material increase in our operating margin during 2016 and 2017. The improving quality of our order book is a function of our strategies of focusing on those business units and regions with the greatest potential to impact our future performance, especially London; aligning ourselves with high quality contractors; and bidding only on those contracts that offer appropriate returns.

 

Within our 2014 full year results statement in March, we noted our intention to introduce a further series of carefully planned structural changes to our organisation, with the clear purpose of driving improved business performance. More recently, we highlighted the disappointing performance of our Cardiff office due to specific contract challenges. Having reviewed the opportunities for our Bristol and Cardiff offices, we have concluded that they are not capable of delivering the quality of opportunity or level of sustainable margins that we require and therefore both will be closed by the end of 2015. The activity of these offices will be reported as a discontinued operation and is expected to incur a pre-tax loss of £2.6m including cash closure costs of £0.3m. All outstanding contractual obligations will be assumed by an expanded TClarke South West.

 

The Group has continued to invest in its engineering and skilled resources to ensure the delivery of our target order book and our intention is to maintain a strict focus on projects where we are either in limited competition or there is a single point of negotiation and where we believe we can return margins that align with our strategy. Increasingly, clients are concerned about the limited availability of high quality resource in our sector. TClarke is regarded as a partner of choice in the sector and this should lead to further opportunities and provides substance to our confidence in future operating margin trends. It remains our strategy not to over-expose the business to any one particular sector and to maintain our project portfolio across our nine target sectors.

 

 

Appointment of Non-Executive Director

 

We are also pleased to announce that Mike Robson, ACA has been appointed as an Independent Non-Executive Director and joined the Group on 18 November 2015.

 

Mike qualified as a Chartered Accountant with PricewaterhouseCoopers ("PWC") and has wide experience of audit, financial management and reporting gained at PWC and in industry. Mike has 23 years Board level experience in a range of business sectors and is currently a Director and partner of Azure Partners which offers strategic consultancy services to Directors and business owners.

 

Mike has been appointed as a member of the Audit Committee, Remuneration Committee and Nomination Committee and will serve as Chairman of the Audit Committee.

 

Mike has a beneficial interest in the Company of 2,000 ordinary shares, representing less than 0.1% of the Company's issued share capital.

 

There are no matters to be disclosed in respect of Mike's appointment under Listing Rule 9.6.13R.

 

Ends

 

For further information contact:

 

TClarke plc

 

Mark Lawrence - Group Chief Executive

Martin Walton - Finance Director

Alexandra Dent - Company Secretary

Tel: 020 7997 7400

www.tclarke.co.uk

 

 

N+1 Singer (Financial Adviser and Broker)

Sandy Fraser

Nick Owen

Tel: 020 7496 3000

www.nplus1singer.com

 

Capital Access Group

Simon Courtenay

Harry Rippon

Tel: 020 3763 3400

www.capitalaccessgroup.co.uk

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSFFSFMAFISEDF
Date   Source Headline
19th Mar 20097:00 amRNSFinal Results
11th Feb 200911:33 amRNSHolding(s) in Company
2nd Feb 20093:59 pmRNSHolding(s) in Company
29th Jan 200911:00 amRNSTrading Statement
22nd Jan 20094:31 pmRNSHolding(s) in Company
22nd Jan 20094:26 pmRNSHolding(s) in Company
19th Jan 20094:28 pmRNSDirector/PDMR Shareholding
16th Jan 20093:13 pmRNSReplacement Director/PDMR Shareholding
15th Jan 20094:35 pmRNSHolding(s) in Company
14th Jan 20094:48 pmRNSDirector/PDMR Shareholding
14th Jan 20094:44 pmRNSDirector/PDMR Shareholding
14th Jan 20093:16 pmRNSDirector/PDMR Shareholding
13th Jan 20097:00 amRNSContract Update
16th Dec 20082:01 pmRNSDirector/PDMR Shareholding
24th Nov 20084:40 pmRNSPrice Monitoring Extension
19th Nov 20082:00 pmRNSDirector/PDMR Shareholding
19th Nov 20087:00 amRNSInterim Management Statement
29th Oct 20084:44 pmRNSSecond Price Monitoring Extn
29th Oct 20084:38 pmRNSPrice Monitoring Extension
7th Oct 20084:45 pmRNSSecond Price Monitoring Extn
7th Oct 20084:38 pmRNSPrice Monitoring Extension
1st Oct 20084:32 pmRNSDirector/PDMR Shareholding
17th Sep 20084:44 pmRNSSecond Price Monitoring Extn
17th Sep 20084:38 pmRNSPrice Monitoring Extension
29th Aug 20087:00 amRNSInterim Results
20th Aug 200811:13 amRNSHolding(s) in Company
20th Aug 20087:00 amRNSHolding(s) in Company
31st Jul 20089:35 amRNSDirectorate Change
18th Jul 20087:00 amRNSTrading Statement
7th Jul 20084:32 pmRNSHolding(s) in Company
1st Jul 200812:40 pmRNSNotice of Results
27th Jun 20081:55 pmRNSDirector/PDMR Shareholding
26th Jun 20082:57 pmRNSDirector/PDMR Shareholding
26th Jun 20089:12 amRNSDirector/PDMR Shareholding
19th Jun 20089:09 amRNSDirector/PDMR Shareholding
2nd Jun 20089:26 amRNSAnnual Information Update
23rd May 20084:24 pmRNSHolding(s) in Company
2nd May 20082:00 pmRNSResult of AGM
2nd May 20087:00 amRNSAGM Statement
8th Apr 200811:09 amRNSAnnual Report and Accounts
28th Mar 20087:01 amRNSFinal Results
12th Mar 20089:18 amRNSStmnt re Share Price Movement
12th Feb 20083:05 pmRNSHolding(s) in Company
30th Jan 20089:23 amRNSNotice of Results
9th Jan 200811:21 amRNSDirector/PDMR Shareholding
27th Nov 200710:48 amRNSDirector/PDMR Shareholding
23rd Nov 200712:09 pmRNSDirector/PDMR Shareholding
19th Nov 20077:01 amRNSTrading Statement
13th Nov 20074:22 pmRNSHolding(s) in Company
24th Oct 20079:10 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.